MoFo BioMeter - Vol. 3, Issue 1, March 2014 - Q4 and FY 2013 BioMeter Shows Rebound in Value for Late Stage Products and Strong Results Across All Stages of Development Regional Analysis Shows SF Leads But Others Are Close (and It’s Not Who You Think)

The full-year 2013 BioMeter analysis shows across-the-board increases in BioMeter value, with an average of $33.9 million for all transactions, up from approximately $21.2 million in 2012. Increases occurred for each stage of development, with the...
By: Morrison & Foerster LLP

Morrison & Foerster LLP